In the recent preso, the company said the phase 1 trial would start in Q2 this year (so Mar-Jun timeline).
But, I think someone mentioned here the trial was pushed back until this time next year?
Can anyone elaborate?
Cheers
Ann: Positive Preclincal Data on Efficacy in New Indication, page-8
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
89.0¢ |
Change
-0.010(1.11%) |
Mkt cap ! $110.0M | |||
| Open | High | Low | Value | Volume |
| 92.0¢ | 92.5¢ | 89.0¢ | $158.1K | 174.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 3825 | 89.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 90.0¢ | 5996 | 1 |
View Market Depth
| Last trade - 15.58pm 10/07/2024 (20 minute delay) ? |
| AGN (ASX) Chart |